ASSOCIATION OF MUSCLE MASS WITH INULIN CLEARANCE-BASED GFR AND INTRAGLOMERULAR HEMODYNAMICS IN HEALTHY SUBJECTS, INDEPENDENT OF FASTING PLASMA GLUCOSE AND AGING

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/245ecf03142d842beececeaf4cbd48c8.pdf
ASSOCIATION OF MUSCLE MASS WITH INULIN CLEARANCE-BASED GFR AND INTRAGLOMERULAR HEMODYNAMICS IN HEALTHY SUBJECTS, INDEPENDENT OF FASTING PLASMA GLUCOSE AND AGING

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Masaya
Yoshimoto
Masaya Yoshimoto 1993ysmtmsy@gmail.com Graduate School of Medicine,Osaka Metropolitan University Metabolism,Endocrinology and Molecular Medicine Osaka Japan *
Akihiro Tsuda naranotsudadesu@omu.ac.jp Graduate School of Medicine,Osaka Metropolitan University Metabolism,Endocrinology and Molecular Medicine Osaka Japan -
Kazuma Sone p21343d@omu.ac.jp Graduate School of Medicine,Osaka Metropolitan University Metabolism,Endocrinology and Molecular Medicine Osaka Japan -
Fumiyuki Morioka j21574d@omu.ac.jp Graduate School of Medicine,Osaka Metropolitan University Metabolism,Endocrinology and Molecular Medicine Osaka Japan -
Yuya Miki mikiy226@omu.ac.jp Graduate School of Medicine,Osaka Metropolitan University Metabolism,Endocrinology and Molecular Medicine Osaka Japan -
Hideki Uedono uedono1217@omu.ac.jp Graduate School of Medicine,Osaka Metropolitan University Metabolism,Endocrinology and Molecular Medicine Osaka Japan -
Shinya Nakatani nakatani-s@omu.ac.jp Graduate School of Medicine,Osaka Metropolitan University Nephrology Osaka Japan -
Yuki Nagata yuki.nagata@omu.ac.jp Graduate School of Medicine,Osaka Metropolitan University Vascular Medicine Osaka Japan -
Yuichi Machida ymachida@omu.ac.jp Graduate School of Medicine,Osaka Metropolitan University Urology Osaka Japan -
Masafumi Kurajoh masafumi-kurajoh@omu.ac.jp Graduate School of Medicine,Osaka Metropolitan University Metabolism,Endocrinology and Molecular Medicine Osaka Japan -
Tomoaki Iwai iwai@omu.ac.jp Graduate School of Medicine,Osaka Metropolitan University Urology Osaka Japan -
Tomoaki Morioka moriokatmed@omu.ac.jp Graduate School of Medicine,Osaka Metropolitan University Metabolism,Endocrinology and Molecular Medicine Osaka Japan -
Junji Uchida uchida@omu.ac.jp Graduate School of Medicine,Osaka Metropolitan University Urology Osaka Japan -
Masanori Emoto emoto-m@omu.ac.jp Graduate School of Medicine,Osaka Metropolitan University Metabolism,Endocrinology and Molecular Medicine Osaka Japan -
-

The prevalence of chronic kidney disease (CKD) is increasing with aging of the population. Inulin clearance (Cin) is the gold standard for determining GFR, which is required for diagnosis of CKD. Diabetes mellitus and hypertension are causes of CKD, and muscle mass and GFR are also related to each other. Aging, hypertension and plasma glucose have been associated with intra-renal hemodynamics, but the relationship of muscle mass with Cin and intrarenal hemodynamics is unclear. Therefore, the aim of this study is to examine the physiological associations underlying the relationship between Cin and muscle mass in healthy subjects.

Cin and para-aminohippurate clearance (CPAH) were measured and computed tomography (CT) was performed in 164 subjects (55.9±10.8 years, 70 males) who were candidates as kidney donors. Intrarenal hemodynamic parameters were calculated by Gomez's formulae. These formulae only apply for Cin >60 ml/min, and thus, only subjects with this value of Cin were included in the analysis. The psoas muscle mass index (PMI) (cm2/m2) was measured on axial CT images by tracing using image analysis software.

PMI was significantly correlated positively with Cin (r = 0.300, p < 0.0001), CPAH (r = 0.322, p < 0.0001) and glomerular hydrostatic pressure (Pglo) (r = 0.297, p < 0.0001), and negatively with vascular resistance at the afferent arteriole (Ra) (r = -0.235, p = 0.002). The following results were obtained in multiple regression analyses with adjustments for several clinical factors. Higher PMI was independently associated with higher Cin (β = 0.233, p = 0.030), CPAH (β = 0.263, p = 0.014), and Pglo (β = 0.212, p = 0.049), and with lower Ra (β = -0.214, p = 0.044), but not with urinary albumin excretion (UAE) (β = 0.054, p = 0.315). Higher fasting plasma glucose (FPG) was independently associated with higher Cin (β = 0.156, p = 0.037) and Pglo (β = 0.158, p = 0.037), but not with CPAH (β = 0.025, p = 0.733) and Ra (β = -0.029, p = 0.694), and with higher resistance at the efferent arteriole (Re) (β = 0.165, p = 0.032) and UAE (β = 0.334, p < 0.0001). Age was independently associated with lower Cin (β = -0.323, p < 0.0001), CPAH (β = -0.242, p = 0.002) and Pglo (β = -0.322, p < 0.0001) and higher Ra (β = 0.388, p < 0.001), but not with UAE (β = -0.031, p = 0.249). 

These results showing different relationships of GFR and intrarenal hemodynamics with muscle mass, FPG and aging may reflect differences in the impact of these factors on endothelial function. UAE has been suggested to develop only when endothelial dysfunction and hyperfiltration coexist. Myokines secreted from skeletal muscle improve both renal plasma flow and endothelial function via nitric oxide. However, to our knowledge, few reports have linked muscle mass to UAE. Endothelial dysfunction and hyperfiltration have been shown to coexist in patients with higher FPG and may lead to UAE. Aging has been associated with endothelial dysfunction, but GFR is physiologically decreased by aging, which suggests that aging might not be associated with UAE.

Muscle mass is associated with Cin and intraglomerular hemodynamics in healthy subjects, independent of FPG and aging.

Kewords